News
Latest information
At the 28th Annual Meeting of the Japanese Telemedicine and Telecare Association (held November 9–10, 2024, at the Okayama Convention Center), Provigate was awarded for its presentation on the development of a minimally/non-invasive home glucose monitoring and behavior modification support system using glycated albumin (GA). Aligned with the conference theme, “Telemedicine for a Smarter Society,” the presentation received the Outstanding Presentation Award.
Provigate is advancing the development of compact home testing devices and diabetes behavior modification support apps based on glycated albumin (GA). Building on our pilot project, the weekly GA testing mail-in service glucoreview®, we plan to expand its availability. Looking ahead, we aim to go beyond mail-in testing by introducing innovative compact home testing devices powered by our unique biosensor technology. Through these initiatives, we are committed to improving the quality of life and optimizing health management for people with diabetes and those at risk of developing the condition.
For further information, please contact:
PROVIGATE, Inc.
e-mail：info@provigate.com
People may think of glucose monitoring as simple as this: "Diabetes is a disease of blood sugar. This is why people with diabetes use glucometer."
However, it's not that simple. Blood sugar measurement has diverse objectives, including diagnosing diabetes, dosing self-injection of insulin, avoiding hypoglycemia due to excessive drug efficacy, and behavior change.
You must choose the appropriate blood sugar measurement method for your purpose.
There are two types of self-blood glucose measurement methods: SMBG (Self-Monitoring of Blood Glucose), which is widely used, and CGM (Continuous Glucose Monitoring), which has become popular in recent years.
These two blood glucose measurement methods are designed mainly for patients who self-inject insulin and other injectable drugs.
Until now, there has been no simple and daily method for measuring blood glucose at home other than these two methods.
Some drugs, such as insulin, are very potent and can cause dangerous hypoglycemia if the dosage is incorrect.
Therefore, for example, those who use insulin must measure their blood glucose accurately before self-injection at home and carefully determine the dose.
After injection, if there are signs of hypoglycemia, it is necessary to measure blood glucose immediately. If necessary, you need to take some sugar to avoid hypoglycemia.
However, both methods have an issue with invasiveness. In addition, they cost a lot. CGM costs at least $60 and needs to be replaced every two weeks, which is also a significant economic burden. SMBG requires frequent measurements, so the total cost becomes significant when accumulated.
Unfortunately, SMBG and CGM are not suitable for everyone due to invasiveness and cost.
Let’s make significant innovations in the era of the healthcare revolution.
We’re looking for talented and enthusiastic individuals to create a better future for everyone.
Copyright© Provigate, Inc. All Rights Reserved.
Back to list 
